Rearranged during Transfection (RET) Inhibitors [MoA] - N0000193947

Pharmacologic Class Information

Pharmacologic Code N0000193947
Pharmacologic Name Rearranged during Transfection (RET) Inhibitors
Pharmacologic Uses
  • kinase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Rearranged during Transfection (RET) Inhibitors

The following table contains 3 products whose active ingredient are classified under the same pharmacologic class Rearranged during Transfection (RET) Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0002-2980Retevmo Non-Proprietary Name: SelpercatinibCapsuleOralEli Lilly And CompanyACTIVE
0002-3977Retevmo Non-Proprietary Name: SelpercatinibCapsuleOralEli Lilly And CompanyACTIVE
50242-210Gavreto Non-Proprietary Name: PralsetinibCapsuleOralGenentech, Inc.ACTIVE